Is HSDB 7463 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use HSDB 7463? Is HSDB 7463 safe for nursing mother and child? Does HSDB 7463 extracts into breast milk? Does HSDB 7463 has any long term or short term side effects on infants? Can HSDB 7463 influence milk supply or can HSDB 7463 decrease milk supply in lactating mothers?
HSDB 7463 lactation summary
- DrLact safety Score for HSDB 7463 is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of HSDB 7463 may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that HSDB 7463 may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using HSDB 7463 .
- Usage of HSDB 7463 is in contradiction to breastfeeding hence if it is must to use HSDB 7463 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About HSDB 7463 usage in lactation
Steroidal aromatase inhibitor. Using this drug while breastfeeding in not recommended
Answer by DrLact: About HSDB 7463 usage in lactation
No information is available on the use of HSDB 7463 during breastfeeding. Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. The manufacturer recommends that breastfeeding be discontinued during HSDB 7463 therapy and for 1 month after the last dose.
Alternate Drugs
Azelaic Acid(Safe)
Erlotinib(Unsafe)
Cladribine(Dangerous)
Vincristine(Dangerous)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Tamoxifen(Dangerous)
Ipilimumab(Unsafe)
Mitoxantrone(Dangerous)
Cetuximab(Unsafe)
Mercaptopurine(Safe)
Carboplatin(Dangerous)
Paclitaxel(Dangerous)
Hydroxyurea(Low Risk)
Letrozole(Dangerous)
Fluorouracil(Dangerous)
Etoposide(Dangerous)
Alemtuzumab(Low Risk)
Nivolumab(Unsafe)
Doxorubicin(Dangerous)
Exemestane(Dangerous)
Rituximab(Low Risk)
Dactinomycin(Dangerous)
Vinblastine(Dangerous)
Cyclophosphamide(Dangerous)
Bevacizumab(Low Risk)
Bleomycin(Dangerous)
Docetaxel(Dangerous)
Cisplatin(Unsafe)
Pazopanib(Unsafe)
Vinorelbine(Dangerous)
Busulfan(Dangerous)
Trastuzumab(Unsafe)
Dacarbazine(Dangerous)
Imatinib(Unsafe)
Gemcitabine(Dangerous)
Thioguanine(Dangerous)
Letrozole(Dangerous)
Exemestane(Dangerous)